CN105726971A - 一种可以促进关节软骨组织修复的中药组合物及应用 - Google Patents
一种可以促进关节软骨组织修复的中药组合物及应用 Download PDFInfo
- Publication number
- CN105726971A CN105726971A CN201610187330.5A CN201610187330A CN105726971A CN 105726971 A CN105726971 A CN 105726971A CN 201610187330 A CN201610187330 A CN 201610187330A CN 105726971 A CN105726971 A CN 105726971A
- Authority
- CN
- China
- Prior art keywords
- parts
- articular cartilage
- cartilage tissue
- medicine composition
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000001188 articular cartilage Anatomy 0.000 title claims abstract description 36
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 230000001737 promoting effect Effects 0.000 title claims abstract description 11
- 230000017423 tissue regeneration Effects 0.000 title claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 210000002826 placenta Anatomy 0.000 claims abstract description 15
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 13
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 13
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 13
- 239000004863 Frankincense Substances 0.000 claims abstract description 13
- 241000258920 Chilopoda Species 0.000 claims abstract description 12
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 12
- 241000545744 Hirudinea Species 0.000 claims abstract description 12
- 241000406668 Loxodonta cyclotis Species 0.000 claims abstract description 12
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 12
- 230000008439 repair process Effects 0.000 claims abstract description 12
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims abstract description 11
- 244000235603 Acacia catechu Species 0.000 claims abstract description 11
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 8
- 239000008280 blood Substances 0.000 claims description 20
- 210000004369 blood Anatomy 0.000 claims description 20
- 241000131329 Carabidae Species 0.000 claims description 11
- 241001148782 Davallia Species 0.000 claims description 11
- 240000007164 Salvia officinalis Species 0.000 claims description 11
- 235000005412 red sage Nutrition 0.000 claims description 11
- 241001313857 Bletilla striata Species 0.000 claims description 9
- 241000427159 Achyranthes Species 0.000 claims description 7
- 210000000988 bone and bone Anatomy 0.000 claims description 5
- 239000012669 liquid formulation Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 238000002663 nebulization Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 240000009023 Myrrhis odorata Species 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 241001251949 Xanthium sibiricum Species 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 241001523383 Achnatherum Species 0.000 claims 2
- 239000000341 volatile oil Substances 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 1
- 239000008213 purified water Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 239000007921 spray Substances 0.000 abstract description 7
- 210000000845 cartilage Anatomy 0.000 abstract description 6
- 210000003321 cartilage cell Anatomy 0.000 abstract description 4
- 230000000451 tissue damage Effects 0.000 abstract description 4
- 231100000827 tissue damage Toxicity 0.000 abstract description 4
- 230000009471 action Effects 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 210000002805 bone matrix Anatomy 0.000 abstract description 2
- 238000011161 development Methods 0.000 abstract description 2
- 230000018109 developmental process Effects 0.000 abstract description 2
- 201000008482 osteoarthritis Diseases 0.000 abstract description 2
- 210000004872 soft tissue Anatomy 0.000 abstract description 2
- 240000000031 Achyranthes bidentata Species 0.000 abstract 1
- 241001313855 Bletilla Species 0.000 abstract 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 244000151637 Sambucus canadensis Species 0.000 abstract 1
- 235000018735 Sambucus canadensis Nutrition 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 235000007123 blue elder Nutrition 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 235000007124 elderberry Nutrition 0.000 abstract 1
- 235000008995 european elder Nutrition 0.000 abstract 1
- 239000000835 fiber Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000000877 morphologic effect Effects 0.000 abstract 1
- 230000000149 penetrating effect Effects 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 15
- 210000000629 knee joint Anatomy 0.000 description 15
- 208000014674 injury Diseases 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 9
- 230000006378 damage Effects 0.000 description 9
- 208000006820 Arthralgia Diseases 0.000 description 7
- 210000003127 knee Anatomy 0.000 description 7
- 230000005499 meniscus Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 230000023597 hemostasis Effects 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000000554 physical therapy Methods 0.000 description 4
- 210000004353 tibial menisci Anatomy 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 241000521257 Hydrops Species 0.000 description 2
- 206010072970 Meniscus injury Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000009692 acute damage Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010007710 Cartilage injury Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010060820 Joint injury Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 208000016593 Knee injury Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 230000001663 anti-spastic effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000000968 fibrocartilage Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 208000018934 joint symptom Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000004417 patella Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及一种可以促进可以促进关节软骨组织修复的中药组合物及应用,该中药组合物由以下重量份的原料组成:紫河车2832份、白芨2832份、土鳖2832份、蜈蚣610份、水蛭812份、儿茶1217份、血褐1217份、丹参1217份、骨碎补1217份、乳香1015份、没药1015份、象皮1015份、云苓712份、牛膝712份及接骨木1013份。该中药组合物制成贴膏或喷雾制剂可用于关节软骨组织损伤后的修复中,具有强力穿透软组织、骨基质、软骨细胞的功效,对阻止软骨内胶原纤维的转型,保护关节软骨细胞,维持软骨的功能和形态的完整性作用明显,对骨关节炎的形成和发展达到有效抑制的目的。
Description
技术领域
本发明涉及一种可以促进关节软骨组织修复的中药组合物及应用,属于医药领域。
背景技术
软骨组织内无血管,软骨细胞在无血运环境中缺乏迁徙能力。因此,关节软骨一旦遭到破坏,便很难得到修复。关节是支撑人体行动的重要部位,软骨组成受损后,抵抗能力下降,长期可以引起风湿性关节炎、类风湿性关节炎及各种风湿疼痛症状。
关节软骨组织损伤如膝关节半月板损伤、踝关节损伤等,膝关节半月板损伤是位于股骨髁与胫骨平台之间的纤维软骨,分内侧半月板和外侧半月板,分别位于膝关节的内外侧间隙间。临床中分为急性损伤期和慢性损伤期,多见急性损伤期;其症状多表现为膝关节疼痛、关节肿胀、伸屈功能障碍、膝关节间隙处压痛,伴屈膝关节时膝部有弹响。
关节软骨组织损伤导致关节软骨可伸张性、抗压力、抗剪切力及软骨通透性降低。中医通常采取中草药物、牵引推拿、针刺针灸、中药外敷、中药熏洗、自然疗法如矿泉浴、运动疗法等方法治疗,效果各异。其中口服中药由于对人的肠胃刺激性较大,不易为患者接受,其它疗法均存在疗效不稳定的缺陷。
发明内容
本发明经过长期地药物筛选、组方优化以及数千例临床验证,提供一种可以促进关节软骨组织修复的中药组合物可以制成贴膏或喷雾制剂可用于关节软骨组织损伤后的修复中,具有强力穿透软组织、骨基质、软骨细胞的功效,对阻止软骨内胶原纤维的转型,保护关节软骨细胞,维持软骨的功能和形态的完整性作用明显,对骨关节炎的形成和发展达到有效抑制的目的。
本发明解决上述技术问题的技术方案如下一种可以促进关节软骨组织修复的中药组合物,由以下重量份的原料组成:紫河车28-32份、白芨28-32份、土鳖28-32份、蜈蚣6-10份、水蛭8-12份、儿茶12-17份、血褐12-17份、丹参12-17份、骨碎补12-17份、乳香10-15份、没药10-15份、象皮10-15份、云苓7-12份、牛膝7-12份及接骨木10-13份。
本发明如上所述一种可以促进关节软骨组织修复的中药组合物,进一步,由以下重量份的原料组成:紫河车30份、白芨30份、土鳖30份、蜈蚣8份、水蛭10份、儿茶15份、血褐15份、丹参15份、骨碎补15份、乳香12份、没药12份、象皮12份、云苓9份、牛膝9份及接骨木11份。
采用本发明上述进一步的有益效果是:采用上述原料的配方可以有效提高软骨组织修复有效率和痊愈率。
本发明如上所述一种可以促进关节软骨组织修复的中药组合物,进一步,由以下重量份的原料组成:紫河车30份、白芨30份、土鳖30份、蜈蚣8份、水蛭10份、儿茶14份、血褐16份、丹参15份、骨碎补15份、乳香13份、没药13份、象皮13份、云苓10份、牛膝10份及接骨木11份。
本发明还提供一种一种关节软骨组织修复贴膏的制备方法,步骤1),按照权利要求1至3任一项所述可以促进关节软骨组织修复的中药组合物的重量份比例称取各个原料,将土鳖、蜈蚣、水蛭及象皮干燥后初级粉碎过80~100目筛,再超微粉碎至粒径在10~50μm范围后灭菌获得第一中药粉末;
步骤2)将紫河车、白芨、儿茶、血褐、丹参、骨碎补、乳香、没药、
云苓、牛膝及接骨木加入纯化水加热回流提取,回流提取的同时收集挥发油成分,提取液过滤、浓缩得到提取物浸膏;
步骤3)将步骤2)获得的提取物浸膏与步骤1制备的第一中药粉末混合均匀制成膏状物,可以添加药物可接受的辅料制备成膏状物,再将步骤2)收集的挥发油喷洒在所述膏状物;取膏状物做成贴膏。
本发明中药物含量科学合理,诸药合用具有活血化瘀、祛风散寒、通经活络、消肿定痛、促进软骨组织再生的功效,可做成膏药,成分高度渗透,对阻止软骨内胶原纤维的转型,保护关节软骨细胞,维持软骨的功能和形态的完整性作用明显,对骨关节炎的形成和发展达到有效抑制的目的,使用方便,疗效稳定,治疗彻底,无任何毒副作用。
本发明所述一种关节软骨组织修复药物的制备方法,进一步,步骤(2)加入原料总重量15~30倍水加热回流提取2次,第一次2小时,第二次1.5小时,合并两次提取液;提取液通过400目滤布进行过滤。
本发明一种关节软骨组织修复喷雾液体制剂,其特征在于,按照上述可以促进关节软骨组织修复的中药组合物的重量份比例称取各个原料,将各原料浸泡在50%的酒精中密封浸泡半年过滤残渣获得喷雾液体制剂。
本发明方法制备喷雾液体制剂药物渗透性好,能够较好的抑制炎症反应,促进软骨组织再生,从而达到止血、止痛、化瘀、消肿修复关节软骨目的,组方严谨、科学高效、无毒无害、见效快、疗程短、只需外用、病人易接受。
本发明可以促进关节软骨组织修复的中药组合物中的原料药物机理如下:
紫河车,紫河车,指人类的胎盘,中医认为,胎盘性味甘、咸、温,入肺、心、肾经,有补肾益精,益气养血之功;
白芨,辛,苦、甘、涩,微寒。归肺、肝、胃经,活血化瘀;
土鳖,破瘀血,续筋骨。用于筋骨折伤,瘀血经闭,症瘕痞块;
蜈蚣,性温,味辛,有毒。具有息风镇痉、攻毒散结、通络止痛之功能。
水蛭,苦,微寒,主逐恶血、瘀血、月闭,破血瘕积聚,无子,利水道。
儿茶,苦、涩,微寒。归肺经,收湿生肌敛疮。用于溃疡不敛,湿疹,口疮,跌扑伤痛,外伤出血。
血褐,跌打损伤,淤血肿痛;
丹参,味苦,微寒,无毒,活血散瘀,镇静止痛。治月经不调,痛经,风湿痹痛,子宫出血,吐血,乳腺炎,痈肿;
骨碎补,活血续筋、补肾强骨。
乳香,性辛、苦、温。入心、肝、脾经。活血,行气、止痛。治瘀阻气滞的脘腹疼痛,风湿痹痛,跌打损伤,痛经,产后腹痛。
没药,主治胸腹瘀痛、痛经、经闭、症瘕、跌打损伤、痈肿疮疡、肠痈、目赤肿痛。有活血止痛、消肿生肌等功效;
象皮,味甘,气平,无毒,活血止血、收敛止血;配防风:活血止痛;祛风胜湿;配乳香:活血止痛,消肿活血祛瘀;
云苓,性平淡,味甘和,无毒性。功能益气安神,健脾和胃,祛除湿热,行水止泄,治疗气虚劳伤、心腹胀满、水肿、腹泻、健忘、失眠等;
牛膝,活血通经、补肝肾、强筋骨、祛风湿、利水通淋。
接骨木,甘、苦,平,无毒,折伤,续筋骨,除风痒龋齿。
本发明科学地采用上述原料及合理用量进行配伍,能够较好的抑制炎症反应,促进软骨组织再生,从而达到止血、止痛、化瘀、消肿修复关节软骨目的,临床观察疗效,有效率可以高达98.5%,治愈率93.5%。
具体实施方式
结合以下实施例对本发明的原理和特征进行描述,所举实例只用于解释本发明,并非用于限定本发明的范围。
实施例1
本发明可以促进关节软骨组织修复的中药组合物,由以下的原料组成:紫河车28g、白芨28g、土鳖28g、蜈蚣6g、水蛭8g、儿茶12g、血褐12g、丹参12g、骨碎补12g、乳香10g、没药10g、象皮10g、云苓7g、牛膝7g及接骨木10g。
采用实施例1中药组合物制成一种关节软骨组织修复贴膏,其具体包括以下步骤:步骤1),按照上述可以促进关节软骨组织修复的中药组合物的比例称取各个原料,将土鳖、蜈蚣、水蛭及象皮干燥后初级粉碎过100目筛,再超微粉碎至粒径在50μm范围后灭菌获得第一中药粉末;
步骤2)将紫河车、白芨、儿茶、血褐、丹参、骨碎补、乳香、没药、
云苓、牛膝及接骨木加入纯化水加热回流提取,回流提取的同时收集挥发油成分,提取液过滤、浓缩得到提取物浸膏;步骤(2)加入原料总重量15~30倍水加热回流提取2次,第一次2小时,第二次1.5小时,合并两次提取液;提取液通过400目滤布进行过滤。
步骤3)将步骤2)获得的提取物浸膏与步骤1制备的第一中药粉末混合均匀制成膏状物,将步骤2)收集的挥发油喷洒在所述膏状物;取膏状物做成贴膏。
实施例2
本发明可以促进关节软骨组织修复的中药组合物,由以下的原料组成:紫河车32g、白芨32g、土鳖32g、蜈蚣10g、水蛭12g、儿茶17g、血褐17g、丹参17g、骨碎补17g、乳香15g、没药15g、象皮15g、云苓12g、牛膝12g及接骨木13g。
采用实施例1中药组合物制成一种关节软骨组织修复贴膏,其具体包括以下步骤:步骤1),按照上述可以促进关节软骨组织修复的中药组合物的比例称取各个原料,将土鳖、蜈蚣、水蛭及象皮干燥后初级粉碎过80目筛,再超微粉碎至粒径在10μm范围后灭菌获得第一中药粉末;
步骤2)将紫河车、白芨、儿茶、血褐、丹参、骨碎补、乳香、没药、
云苓、牛膝及接骨木加入纯化水加热回流提取,回流提取的同时收集挥发油成分,提取液过滤、浓缩得到提取物浸膏;步骤(2)加入原料总重量15~30倍水加热回流提取2次,第一次2小时,第二次1.5小时,合并两次提取液;提取液通过400目滤布进行过滤。
步骤3)将步骤2)获得的提取物浸膏与步骤1制备的第一中药粉末混合均匀制成膏状物,将步骤2)收集的挥发油喷洒在所述膏状物;取膏状物做成贴膏。
实施例3
本发明可以促进关节软骨组织修复的中药组合物,由以下的原料组成:紫河车30g、白芨30g、土鳖30g、蜈蚣8g、水蛭10g、儿茶15g、血褐15g、丹参15g、骨碎补15g、乳香12g、没药12g、象皮12g、云苓9g、牛膝9g及接骨木11g。
采用实施例1中药组合物制成一种关节软骨组织修复贴膏,其具体包括以下步骤:步骤1),按照上述可以促进关节软骨组织修复的中药组合物的比例称取各个原料,将土鳖、蜈蚣、水蛭及象皮干燥后初级粉碎过80~100目筛,再超微粉碎至粒径在10~50μm范围后灭菌获得第一中药粉末;
步骤2)将紫河车、白芨、儿茶、血褐、丹参、骨碎补、乳香、没药、
云苓、牛膝及接骨木加入纯化水加热回流提取,回流提取的同时收集挥发油成分,提取液过滤、浓缩得到提取物浸膏;步骤(2)加入原料总重量15~30倍水加热回流提取2次,第一次2小时,第二次1.5小时,合并两次提取液;提取液通过400目滤布进行过滤。
步骤3)将步骤2)获得的提取物浸膏与步骤1制备的第一中药粉末混合均匀制成膏状物,将步骤2)收集的挥发油喷洒在所述膏状物;取膏状物做成贴膏。
实施例4
本发明可以促进关节软骨组织修复的中药组合物,由以下的原料组成:由以下的原料组成:紫河车30g、白芨30g、土鳖30g、蜈蚣8g、水蛭10g、儿茶14g、血褐16g、丹参15g、骨碎补15g、乳香13g、没药13g、象皮13g、云苓10g、牛膝10g及接骨木11g。
采用实施例4中药组合物制成一种关节软骨组织修复贴膏,其具体包括以下步骤:步骤1),按照权利要求1至3任一项所述可以促进关节软骨组织修复的中药组合物的比例称取各个原料,将土鳖、蜈蚣、水蛭及象皮干燥后初级粉碎过80~100目筛,再超微粉碎至粒径在10~50μm范围后灭菌获得第一中药粉末;
步骤2)将紫河车、白芨、儿茶、血褐、丹参、骨碎补、乳香、没药、
云苓、牛膝及接骨木加入纯化水加热回流提取,回流提取的同时收集挥发油成分,提取液过滤、浓缩得到提取物浸膏;所述加入纯化水加热回流提取具体是加入原料总重量15~30倍水加热回流提取2次,第一次2小时,第二次1.5小时,合并两次提取液;提取液通过400目滤布进行过滤。
步骤3)将步骤2)获得的提取物浸膏与步骤1制备的第一中药粉末混合均匀制成膏状物,将步骤2)收集的挥发油喷洒在所述膏状物;取膏状物做成贴膏。
本发明一种关节软骨组织修复喷雾液体制剂,其特征在于,按照权利要求1至3任一项所述可以促进关节软骨组织修复的中药组合物的比例称取各个原料,将各原料浸泡在50%的酒精中浸泡半年过滤残渣获得喷雾液体制剂。
实施例5
按照实施例3的可以促进关节软骨组织修复的中药组合物的重量比例称取各个原料,将各原料浸泡在50%的酒精中浸泡半年过滤残渣获得喷雾液体制剂。
本发明的临床实践效果例如下:
临床资料:发明人自2004年至2015年,对某市800例膝关节半月板损伤患者进行临床观察,其中男510例,女670例,年龄在25~72岁之间,病情诊断采信8个正规医院出具的报告。
治疗方法是:贴服,一日一次,每次贴服10-16小时,持续7天一疗程,每个疗程中间各3-5天,连续用药3-10个疗程。
喷雾制剂每天喷3-5次,持续7天一疗程,每个疗程中间各2-5天,连续用药2-10个疗程。
疗效判定标准:痊愈:膝关节肿胀完全消失,关节活动和步行均无其他不适。全身无阳性体征可查;
好转:膝关节肿痛明显减轻,体征基本消失;
无效:膝关节肿痛等症状减轻,活动略重则关节疼痛加重;
服用实施例1中药产品的膝关节半月板损伤患者100位。根据病情严重程度,连续用药5-8个疗程,临床结果:痊愈60例,好转22例、无效18例,总有效率为82%,痊愈率60%。
服用实施例2中药产品膝关节半月板损伤患者150。根据病情严重程度,连续用药5-10个疗程,临床结果:痊愈100例,好转35例,无效15例,总有效率为90%,痊愈率66.7%。
服用实施例3中药产品膝关节半月板损伤患者201位。根据病情严重程度,连续用药3-6个疗程,临床结果:痊愈188例,好转10例,无效3例,总有效率为98.5%,痊愈率93.5%。
服用实施例4中药产品脑出血患者115位。根据病情严重程度,连续用药4-8个疗程,临床结果:痊愈89例,好转15例,无效11例,总有效率为90.4%,痊愈率77.4%。
服用实施例5中药产品治疗脑出血患者230位。根据病情严重程度,连续用药3-6个疗程,临床结果:治愈210例,好转12例,无效8例,总有效率为96.6%,痊愈率91.3%。
经过8个正规医院出具的报告经过3至10个疗程,有效率可以高98.5%,治愈率93.5%
从以上效果例可以看出本发明实施例3的的可以促进关节软骨组织修复的中药组合物重量百分比例对膝关节半月板损伤具有较好的治愈率。
以下列举几个典型病例
谢某某,男,49岁,2010年7月因骑车不慎跌倒后致右膝关节损伤,一日后肿胀疼痛、活动受限,在我院诊为右膝关节半月板损伤,使用本发明药物治疗一个疗程后痊愈。随访一年未复发
关某,男,47岁,因外伤致右膝关节半月板损伤,活动受限、不能行走,使用本发明实施例1药物治疗8个疗程后痊愈。随访一年未复发
李某,男,48岁,膝关节疼痛一年之久,活动受限、上下坡时明显,曾在当地医院诊为慢性膝关节损伤,多方治疗效果不佳,使用本发明实施例3药物4个疗程后痊愈。随访一年未复发。
秦某,男,28岁,因打篮球扭伤左膝肿痛7天入院,检查关节浮肿,浮髌,压痛明显,关节不能活动,经卧床休息及理疗肿痛部分消退,于伤后20天行关节空气造影证实为左膝外侧半月板损伤,关节仍有肿胀,反复积液,经多次抽液及理疗症状无明显改善,于是给用本发明实施例31个疗程后症状明显改善,疼痛减轻,膝关节肿胀明,使用5个疗程后基本痊愈。
顾某,女,27岁,足球球运动员,因训练扭伤右膝关节,疼痛不止,关节屈伸活动障碍,屈伸时有弹响,影响训练,经门诊碘水造影检查诊断为右膝外侧半月板撕裂,于是入院进行半月板切除,术后仍见关节反复肿痛、积液,经多次抽液及理疗症状无明显改善,于是给用本发明实施例5方法制备的喷雾制剂,使用3天月后关节疼痛明显减轻,关节肿胀明显,使用一个疗程关节肿胀消失,使用4个疗程痊愈。
吴某,男,48岁,因不慎跌倒致膝关节有剧痛、肿胀,起立蹲下困难,且不能自动伸直,走路可伴有弹响,于门诊检查诊断为左膝外侧盘状半月板损伤,经多次理疗症状无明显改善,于是给用本发明实施例5制剂,使用1个疗程后关节、肿胀疼痛明显减轻,可起立蹲下、正常走路,继续使用3个疗程后上述症状消失,6个疗程后全愈,随访2年未见复发。
以上所述仅为本发明的较佳实施例,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (7)
1.一种可以促进关节软骨组织修复的中药组合物,其特征在于,由以下重量份的原料组成:紫河车28-32份、白芨28-32份、土鳖28-32份、蜈蚣6-10份、水蛭8-12份、儿茶12-17份、血褐12-17份、丹参12-17份、骨碎补12-17份、乳香10-15份、没药10-15份、象皮10-15份、云苓7-12份、牛膝7-12份及接骨木10-13份。
2.根据权利要求1所述一种可以促进关节软骨组织修复的中药组合物,其特征在于,由以下重量份的原料组成:紫河车30份、白芨30份、土鳖30份、蜈蚣8份、水蛭10份、儿茶15份、血褐15份、丹参15份、骨碎补15份、乳香12份、没药12份、象皮12份、云苓9份、牛膝9份及接骨木11份。
3.根据权利要求1所述一种可以促进关节软骨组织修复的中药组合物,其特征在于,由以下重量份的原料组成:紫河车30份、白芨30份、土鳖30份、蜈蚣8份、水蛭10份、儿茶14份、血褐16份、丹参15份、骨碎补15份、乳香13份、没药13份、象皮13份、云苓10份、牛膝10份及接骨木11份。
4.一种可以促进关节软骨组织修复的中药组合物在治疗关节软骨组织修复药物中的应用。
5.一种关节软骨组织修复贴膏的制备方法,其特征在于,步骤1),按照权利要求1至3任一项所述可以促进关节软骨组织修复的中药组合物的重量份比例称取各个原料,将土鳖、蜈蚣、水蛭及象皮干燥后初级粉碎过80~100目筛,再超微粉碎至粒径在10~50μm范围后灭菌获得第一中药粉末;
步骤2)将紫河车、白芨、儿茶、血褐、丹参、骨碎补、乳香、没药、云苓、牛膝及接骨木加入纯化水加热回流提取,回流提取的同时收集挥发油成分,提取液过滤、浓缩得到提取物浸膏;
步骤3)将步骤2)获得的提取物浸膏与步骤1制备的第一中药粉末混合均匀制成膏状物,将步骤2)收集的挥发油喷洒在所述膏状物;取膏状物做成贴膏。
6.根据权利要求5所述一种关节软骨组织修复胶囊的制备方法,其特征在于,步骤(2)加入原料总重量15~30倍水加热回流提取2次,第一次2小时,第二次1.5小时,合并两次提取液;提取液通过400目滤布进行过滤。
7.一种关节软骨组织修复喷雾液体制剂的制备方法,其特征在于,按照权利要求1至3任一项所述可以促进关节软骨组织修复的中药组合物的重量份比例称取各个原料,将各原料浸泡在50%的酒精中密封浸泡半年过滤残渣获得喷雾液体制剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610187330.5A CN105726971A (zh) | 2016-03-29 | 2016-03-29 | 一种可以促进关节软骨组织修复的中药组合物及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610187330.5A CN105726971A (zh) | 2016-03-29 | 2016-03-29 | 一种可以促进关节软骨组织修复的中药组合物及应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105726971A true CN105726971A (zh) | 2016-07-06 |
Family
ID=56252253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610187330.5A Pending CN105726971A (zh) | 2016-03-29 | 2016-03-29 | 一种可以促进关节软骨组织修复的中药组合物及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105726971A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1084761A (zh) * | 1993-07-29 | 1994-04-06 | 夏树安 | 骨伤灵 |
CN100998799A (zh) * | 2006-12-27 | 2007-07-18 | 陈玉龙 | 一种治疗骨折、跌打损伤的中药制剂 |
CN102319332A (zh) * | 2011-09-28 | 2012-01-18 | 吴淑玺 | 一种麝香接骨续筋中药组合物 |
-
2016
- 2016-03-29 CN CN201610187330.5A patent/CN105726971A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1084761A (zh) * | 1993-07-29 | 1994-04-06 | 夏树安 | 骨伤灵 |
CN100998799A (zh) * | 2006-12-27 | 2007-07-18 | 陈玉龙 | 一种治疗骨折、跌打损伤的中药制剂 |
CN102319332A (zh) * | 2011-09-28 | 2012-01-18 | 吴淑玺 | 一种麝香接骨续筋中药组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104147577B (zh) | 一种用于促进骨痂生长治疗骨折的膏药 | |
CN102552637B (zh) | 治疗肩周炎的中药组合物及其制备方法 | |
CN106492133A (zh) | 一种接骨续筋、活血化瘀、消肿止痛的中药膏药及制备方法 | |
CN103536858B (zh) | 一种治疗类风湿性关节炎的药物 | |
CN106581454A (zh) | 一种用于治疗骨伤颈肩腰腿病的中草药组合物及其制备方法 | |
CN104258278B (zh) | 骨伤灵喷雾剂 | |
CN105560662A (zh) | 一种治疗膝关节骨性关节炎的外用中药组合物 | |
CN102228586B (zh) | 一种促进骨伤骨折愈合的药膏及其制备方法 | |
CN104784639B (zh) | 修复软骨组织损伤的中药组合物、制剂、制备方法和应用 | |
CN104547117B (zh) | 一种治疗膝关节滑膜炎的中药制剂 | |
CN102861196A (zh) | 一种接骨中药 | |
CN103223081B (zh) | 一种治疗关节炎及跌打损伤的青草油 | |
CN104983965A (zh) | 一种中药组合物 | |
CN104800443B (zh) | 一种补肾生髓续骨剂 | |
CN103585483B (zh) | 一种治疗膝骨性关节病的中药组合物及其制备方法 | |
CN105726971A (zh) | 一种可以促进关节软骨组织修复的中药组合物及应用 | |
CN106215051A (zh) | 一种治疗周围神经损伤的中西复方药物及制备方法 | |
CN106309849A (zh) | 一种足浴用藏药组合物及其应用 | |
CN105267415A (zh) | 一种治疗骨髓炎的中药组合物 | |
CN105288006A (zh) | 一种接骨及治疗骨折、跌打损伤的膏药及其制备方法 | |
CN104225533A (zh) | 一种中药组合物及其制备方法 | |
CN106924673A (zh) | 一种治疗骨质增生的中药组合物及其药剂制备方法 | |
CN107998235A (zh) | 治疗踝关节扭伤的复方壮药物及其制备方法 | |
CN106177775A (zh) | 一种治疗骨质增生的中药组合物 | |
CN103055216B (zh) | 溯源性三原态共轭正骨复位养生中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160706 |